caduet
pfizer australia pty ltd - amlodipine besylate; atorvastatin calcium -
caduet 10 mg, 5 mg
مستودع ادوية الصباغ - sabbagh drug store - atorvastatin 10 mg, amlodipine 5 mg - 10 mg, 5 mg
caduet 40 mg, 5 mg
مستودع ادوية الصباغ - sabbagh drug store - atorvastatin 40 mg, amlodipine 5 mg - 40 mg, 5 mg
caduet film-coated tablet 5mg/10mg
upjohn (malaysia) sdn. bhd. - amlodipine besylate; atorvastatin calcium -
caduet film-coated tablet 5mg/40mg
upjohn (malaysia) sdn. bhd. - atorvastatin calcium; amlodipine besylate -
caduet film-coated tablet 5mg/20mg
upjohn (malaysia) sdn. bhd. - atorvastatin calcium; amlodipine besylate -
caduet film-coated tablet 10mg/20mg
upjohn (malaysia) sdn. bhd. - atorvastatin calcium; amlodipine besylate -
caduet film-coated tablet 10mg/40mg
upjohn (malaysia) sdn. bhd. - atorvastatin calcium; amlodipine besylate -
caduet film-coated tablet 10mg/10mg
upjohn (malaysia) sdn. bhd. - amlodipine besylate; atorvastatin calcium -
caduet ® 5/10
pfizer pharmaceuticals israel ltd - amlodipine as besylate 5 mg; atorvastatin as calcium 10 mg - film coated tablets - amlodipine - caduet (amlodipine and atorvastatin ) is indicated in patients for whom treatment with both amlodipine and atorvastatin is apptopriate. amlodipine: - hypertension - chronic stable angina - vasospastic angina (prinzmetal's or variant angina). atorvastatin : - prevention of cardiovascular disease - heterozygous familial and nonfamilial hypercholesterolemia - elevated serum tg levels - primary dysbetalipoproteinemia - homozygous familial hypercholesterolemia - pediatric patients (10-17 years of age) : atorvastatin is indicated as an adjunct to diet to reduce total -c ldl-c and apo b levels in boys and postmenarchal girls 10 to 17 years of age with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present: 1. ldl-c remains >or = 190 mg/dl or 2. ldl-c remains > or = 160 mg/dl and: there is a positive family history of premature cardiovascular disease or two or more other cvd risk factors are present in the pediatric patient.